Use of a systematic risk analysis method to improve safety in the production or paediatric parenteral nutrition solutions

Quality and Safety in Health Care

Volumn 14, Issue 2, 2005, Pages 93-98

  Bonnabry, P ^a   Cingria, L ^a   Sadeghipour, F ^a   Ing, H ^a   Fonzo Christe, C ^a   Pfister, R E ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CHILD NUTRITION; DATA ANALYSIS; HIGH RISK PATIENT; HUMAN; MICROBIOLOGICAL EXAMINATION; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PRESCRIPTION; QUALITY CONTROL; RELIABILITY; RISK REDUCTION; SAFETY;

CHILD; CHILD NUTRITION PHYSIOLOGY; CHILD, PRESCHOOL; DRUG COMPOUNDING; DRUG LABELING; ENVIRONMENT, CONTROLLED; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MEDICATION ERRORS; PARENTERAL NUTRITION; PHARMACEUTICAL SOLUTIONS; PHARMACY SERVICE, HOSPITAL; PROCESS ASSESSMENT (HEALTH CARE); RISK ASSESSMENT; SAFETY MANAGEMENT; SWITZERLAND; SYSTEMS ANALYSIS;

EID: 17144397201     PISSN: 14753898     EISSN: None     Source Type: Journal    
DOI: 10.1136/qshc.2003.007914     Document Type: Article

References (41)

1. Pichard C, Mühlebach S, Maisonneuve N, et al. Prospective survey of parenteral nutrition in Switzerland: a three-year nation-wide survey. Clin Nutr 2001;20:345-50.
2. Allwood MC. Pharmaceutical aspects of parenteral nutrition: from now to the future. Nutrition 2000;16:615-8.
3. Heird WC, Driscoll JM, Schullinger JN, et al. Intravenous alimentation in pediatric patients. J Pediatr 1972;80:351-72.
4. Santell JP, Kamalich RF. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities 1995. Am J Health-Syst Pharm 1996;53:2591-605.
5. Flynn EA, Pearson RE, Barker KN. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Am J Health-Syst Pharm 1997;54:904-12.
6. Driscoll DF, Bacon M, Provost PS, et al. Automated compounders for parenteral nutrition admixtures. JPEN 1994;18:385-6.
7. Blok D, Vermelj P. Automated dispensing and mixing machines in the preparation of parenteral nutrition. Experience with the MicroMacro compounder. Eur J Hosp Pharm 1995;1:150-4.
8. Combeau D, Rey JB, Fontan JE, et al. Baxa MicroMacrocompounder for parenteral nutrition solutions in a pediatric hospital. PDA J Pharm Sciences Technol 1999;53:226-30.
9. Bethune K, Duncombe R. The use of automated compounding devices. Hosp Pharm Eur 2002;1:39-40.
10. Combeau D, Rey JB, Rieutord A, et al. Accuracy of two filling systems for parenteral nutrient solutions. Am J Health-Syst Pharm 1998;55:1606-10.
11. Johnson R, Coles BJ, Tribble DA. Accuracy of three compounding systems determined by end-product laboratory testing and comparison with manual preparation. Am J Health-Syst Pharm 1998;55:1503-7.
12. Dickson LB. Automated compounder for adding ingredients to parenteral nutrient base solutions. Am J Hosp Pharm 1993;50:678-82.
13. Mitchell KA, Jones EA, Meguid MM, et al. Standardized TPN order form reduces staff time and potential for error. Nutrition 1990;6:457-60.
14. Storm HM, Young SL, Sandler RH. Development of pediatric and neonatal parenteral nutrition order forms. Nutr Clin Practice 1995;10:54-9.
15. DiDonato IJ. Use of the handheld programmable calculator in the preparation of TPN solutions. Hosp Pharm 1983;18:531-3.
16. May F, Robbins G. A computer program for parenteral nutrition solution preparation. JPEN 1978;2:646-51.
17. MacMahon P. Prescribing and formulating neonatal intravenous feeding solutions by microcomputer. Arch Dis Child 1984;59:548-52.
18. Vandenplas Y, De Belder B, Bougatef A, et al. Computerized prescription of total parenteral nutrition in pediatrics. Acta Anaesthesiol Belg 1987;38:59-62.
19. Picart D, Guillois B, Nevo L, et al. A program for parenteral and combined parenteral and enteral nutrition of neonates and children in an intensive care unit. Intensive Care Med 1989;15:279-82.
20. Schloerb PR. Electronic parenteral and enteral nutrition. JPEN 2000;24:23-9.
21. Mc Lellan N. Microcomputer organization of parenteral nutrition of the neonate. J Clin Hosp Pharm 1983;8:147-51.
22. Horn W, Popow C, Miksch S, et al. Development and evaluation of VIE-PNN, a knowledge-based system for calculating the parenteral nutrition of newborn infants. Arfif Intell Med 2002;24:217-28.
23. Joint Commission on Accreditation of Healthcare Organizations. Medical errors, sentinel events, and accreditation. A report to the Association of Anesthesia Programs Directors, 2000.
24. Aspen P, Corrigan JM, Wolcott J, et al. Patient safety: achieving a new standard of care. Washington, DC: The National Academic Press, 2003.
25. McDonough JE, Soloman R, Petrosa L. Quality improvement and proactive hazard analysis models: deciphering a new tower of Babel. In: Aspen P, Corrigan JM, Wolcott J, Erikson SM, eds. Patient safety: achieving a new standard of care. Washington, DC: National Academic Press, 2003.
26. Institute for Healthcare Improvement. Failure modes and effects analysis (FMEA). www.QualityHealthCare.org, 2003.
27. Marx DA, Slonim AD. Assessing patient safety risk before the injury occurs: an introduction to sociotechnical probabilistic risk modelling in health care. Qual Saf Health Care 2003;12(Suppl II):ii33-8.
28. Burgmeier J. Failure mode and effect analysis: an application in reducing risk in blood transfusion. Jt Comm J Qual Improv 2002;28:331-9.
29. Hergon E, Rouger P, Garnerin P. Preventing deficiencies in the transfusion process. Transtus Clin Biol 1994;1:455-65.
30. Hergon E, Crespeau H, Rouger P. Failure mechanisms in the transfusion process. Importance of anticipatory operational safety analysis. Transfus Clin Biol 1994;1:379-86.
31. Marey A, Coupez B, Gruca L, et al. Impact of a quality approach for transfusion safety: prescription, circuit optimization, traceability. Transfus Clin Biol 1997;4:469-84.
32. Saizy-Callaert S, Causse R, Thebault A, et al. Analysis of mode of failure, their effects and criticality: improving of the hospital drug prescribing process. Therapie 2001;56:525-31.
33. McNally KM, Page MA, Sunderland VB. Failure-mode and effects analysis in improving drug distribution system. Am J Health Syst Pharm 1997;15:171-7.
34. Willis G. Failure mode and effects analysis in clinical engineering. J Clin Eng 1992;17:59-63.
35. Leape LL. A systems analysis approach to medical errors. J Eval Clin Pract 1997;3:213-22.
36. Cohen MR, Senders J, Davis NM. Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm 1994;29:319-30.
37. Fletcher CE. Failure mode and effects analysis. An interdisciplinary way to analyze and reduce medication errors. J Nurs Admin 1997;27:19-26.
38. De Rosier J, Stalhandske E, Bagian JP, et al. Using health care failure mode and effect analysis: the VA national center for patient safety's prospective risk analysis system. J Qual Improv 2002;28:248-67.
39. Williams E. The use of failure mode effect and criticality analysis in a medication error subcommittee. Hosp Pharm 1994;29:331-7.
40. Ing H, Pfister R, Fonzo-Christe C, et al. Développement d'un programme de prescription des alimentations parentérales totales pédiatriques. Schweiz Med Forum 2002;(Suppl 10):28S.
41. Sadeghipour F, Ing H, Sierra C, et al. Validation of paediatric total parenteral nutrient solutions production with Baxa MM12 automated compounder. Clin Nutr 2002;21(Suppl 1):82.